EUVIMEDEUVIMED entdecken
Crossref

Activation of Sirt1 by Glyasperin F Suppresses PI3K /Akt/ HIF ‐1α Signaling and Inhibits Glycolytic Metabolism to Ameliorate Pathology in Rheumatoid Arthritis‐Associated Interstitial Lung Disease

Hui Yuan iD, Wei Leng, Nan Yu, Yong Yu, Chuangbo Yang, Yanrong Bai, Xinxin Xia, Yue Wang

The FASEB Journal · 15.06.2026 · 40 (11)

DOI: 10.1096/fj.202503559rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 30.05.2026. Verfasst von Hui Yuan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Immunology and Hematology, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, China. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, alpha Subunit, Proto-Oncogene Proteins c-akt, Glycolysis, Lung Diseases, Interstitial. Die Arbeit nennt 41 Literaturangaben. Gefördert von: The National Natural Science Foundation of China, The Natural Science Basic Research Program of Shaanxi Province, The Qinchuangyuan Traditional Chinese Medicine Industry Innovation Agglomeration Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis‐associated interstitial lung disease (RA‐ILD) is a severe extra‐articular complication with limited treatment options. This study identified Glyasperin F, a flavonoid derived from licorice and dried ginger decoction, as a potent inhibitor of glycolytic reprogramming in RA‐ILD. Using a murine model combining collagen‐induced arthritis and bleomycin‐induced pulmonary fibrosis, we demonstrated that Glyasperin F significantly alleviated joint inflammation and pulmonary fibrosis. An in vitro inflammatory–fibrotic model was established by co‐stimulating MRC‐5 human lung fibroblasts with TGF‐ β 1 and IL‐1 β . This model was combined with pharmacological modulation of Sirt1 using EX527 and SRT1720, as well as HIF‐1 α overexpression or empty‐vector lentiviral transduction, to dissect the underlying molecular mechanisms. Mechanistically, Glyasperin F upregulated Sirt1, thereby suppressing the PI3K/Akt/HIF‐1 α pathway, downregulating key glycolytic enzymes (HK2, PFK, PKM2, LDHA), and reducing lactate/ATP production and oxidative stress. HIF‐1 α overexpression reversed these therapeutic effects. This study suggests that Glyasperin F has the potential to serve as a natural candidate compound for the regulation of glycolytic metabolism in the intervention of RA‐ILD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoxia-Inducible Factor 1, alpha SubunitProto-Oncogene Proteins c-aktGlycolysisLung Diseases, InterstitialArthritis, RheumatoidSirtuin 1Signal TransductionPhosphatidylinositol 3-KinasesAnimalsHumansMiceMaleMice, Inbred C57BL

Stichwörter der Autor:innen

Glyasperin FSirtuin 1glycolysishypoxia‐inducible factor 1‐alphaphosphoinositide 3‐kinase/protein kinase Brheumatoid arthritis‐associated interstitial lung disease

Substanzen

Hypoxia-Inducible Factor 1, alpha SubunitProto-Oncogene Proteins c-aktSirtuin 1Phosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • Department of Rheumatology, Immunology and Hematology, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, China.
  • Department of Rheumatology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
  • College of Medical Technology, Shaanxi University of Chinese Medicine, Xianyang, China.
  • Department of Radiology, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, China.
  • Department of Traditional Chinese Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

ORCID-Profile: Hui Yuan

Förderung

  • The National Natural Science Foundation of China
  • The Natural Science Basic Research Program of Shaanxi Province
  • The Qinchuangyuan Traditional Chinese Medicine Industry Innovation Agglomeration Project
  • The Shaanxi Provincial Excellent Traditional Chinese Medicine Talent Training Project.

Zitieren

APA

Yuan, H., Leng, W., Yu, N., Yu, Y., Yang, C., Bai, Y., Xia, X., & Wang, Y. (2026). Activation of Sirt1 by Glyasperin F Suppresses PI3K /Akt/ HIF ‐1α Signaling and Inhibits Glycolytic Metabolism to Ameliorate Pathology in Rheumatoid Arthritis‐Associated Interstitial Lung Disease. The FASEB Journal, 40(11). https://doi.org/10.1096/fj.202503559rr

Vancouver

Yuan H, Leng W, Yu N, Yu Y, Yang C, Bai Y, et al. Activation of Sirt1 by Glyasperin F Suppresses PI3K /Akt/ HIF ‐1α Signaling and Inhibits Glycolytic Metabolism to Ameliorate Pathology in Rheumatoid Arthritis‐Associated Interstitial Lung Disease. The FASEB Journal. 2026;40(11). doi:10.1096/fj.202503559rr

BibTeX
@article{Yuan2026,
  author = {Yuan, Hui and Leng, Wei and Yu, Nan and Yu, Yong and Yang, Chuangbo and Bai, Yanrong and Xia, Xinxin and Wang, Yue},
  title = {Activation of Sirt1 by Glyasperin F Suppresses PI3K /Akt/ HIF ‐1α Signaling and Inhibits Glycolytic Metabolism to Ameliorate Pathology in Rheumatoid Arthritis‐Associated Interstitial Lung Disease},
  journal = {The FASEB Journal},
  year = {2026},
  volume = {40},
  number = {11},
  doi = {10.1096/fj.202503559rr}
}
Kostenlos starten →